The abstract highlights the significant impact of GLP-1 medications, such as Ozempic and Wegovy, on food purchasing behaviors. Households with users of these medications show notable reductions in grocery spending, particularly on calorie-dense, processed foods, while increasing purchases of nutrient-dense items like fresh produce. The shift away from fast food and coffee shops during meal times further underscores how GLP-1 adoption could reshape consumer demand and have broader implications for the food industry. This suggests the potential for these medications to drive healthier eating habits at a population level.

@dwr.eth